Amazon Biotech Inc. recorded its most recent insider trading activity on May 2, 2005. Chief Technology Officer Chaim Justman executed multiple sell transactions during early 2005. Prior to these events, Secretary and Treasurer Michael Vardakis sold shares in February 2004. No significant market movements are noted given the age of these filings.